12 Health Care Stocks Moving In Tuesday's Intraday Session
Portfolio Pulse from Benzinga Insights
Health care stocks experienced significant movements in Tuesday's intraday session, with notable gainers including Nexalin Technology, MSP Recovery, and Aditxt, among others. Losers were led by Acorda Therapeutics, Gritstone Bio, and Orgenesis. Factors influencing these movements include recent earnings reports for some companies.
April 02, 2024 | 4:31 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Acorda Therapeutics stock plummeted by 75.8% to $3.26, with a market cap of $4.0 million, following its Q4 earnings report.
The drastic drop in Acorda Therapeutics' stock price post-earnings suggests a negative investor reaction to the Q4 results, likely leading to continued bearish sentiment in the short term.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 95
POSITIVE IMPACT
Evaxion Biotech's stock rose 16.4% to $3.76, with a market cap of $18.0 million, following its Q4 earnings report four days ago.
Evaxion Biotech's recent earnings report appears to have positively influenced investor sentiment, contributing to the stock's rise and possibly more gains in the short term.
CONFIDENCE 80
IMPORTANCE 75
RELEVANCE 85
POSITIVE IMPACT
Nexalin Technology stock surged 47.9% to $2.81, with a market cap of $20.4 million.
The significant surge in Nexalin Technology's stock price could attract more investor interest in the short term, potentially maintaining upward price momentum.
CONFIDENCE 85
IMPORTANCE 80
RELEVANCE 90